Pharmacogenetics

I. Hall (Nottingham, United Kingdom)

Source: Annual Congress 2005 - MP15 - Pharmacogenetics
Session: MP15 - Pharmacogenetics
Session type: Meet the Professor
Number: 4164
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Hall (Nottingham, United Kingdom). Pharmacogenetics. Annual Congress 2005 - MP15 - Pharmacogenetics

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Introduction: pharmacogenetic approaches in the treatment of asthma
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005

Gene polymorphisms in bronchial asthma
Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases
Year: 2007



Recent developments in the genetics of asthma susceptibility and severity
Source: Eur Respir Mon 2011; 51: 82-96
Year: 2011


Genes, the environment and the lung
Source: Annual Congress 2006 - Genes, environment and the lung
Year: 2006


New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005


The genetics of asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=26
Year: 2003

New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


The role of CD14, TLR2, and TLR4 genetic polymorphisms in atopy and new onset asthma in young Danish farmers: a nested case-control study
Source: Annual Congress 2007 - Occupation and obstruction
Year: 2007



Single nucleotide polymorphism and asthma: A study on the genetic basis of asthma
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015


Genome-wide association study identifies new COPD risk locus, PDE4D, in Korean population
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013


The role of genetic factors in occupational asthma
Source: Eur Respir J 2003; 22: 173-178
Year: 2003



Impact of genetic factors on lung development in health and disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=93
Year: 2006

Favorable human safety, pharmacokinetics and pharmacodynamics of the autotaxin inhibitor GLPG1690, a potential new treatment in COPD
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015



FKBP5 a candidate for corticosteroid insensitivity in COPD
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016


GSTM1, GSTT1 polymorphisms, chronic allergic rhinitis and risk of asthma: a case-control study in Ukrainian population
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005


Pharmacological treatment of asthma today
Source: Eur Respir J 2001; 18: 34S-40S
Year: 2001



Association of genetic variations of CC chemokine receptor-2 (CCR2) with atopic asthma, but not with nonatopic asthma
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005


Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013